Brain Stem Stroke Clinical Trials
2 recruiting trials for Brain Stem Stroke. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Brain Stem Stroke clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Neuralink Corp (1), Johns Hopkins University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is N1 Implant (device, 1 trial), followed by R1 Robot, INTENT Neural Interface System.
Track Brain Stem Stroke trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External...
The UAE-PRIME Study is a feasibility study designed to assess the initial clinical safety and functionality of the Neuralink N1 Implant and R1 Robot. This study involves...
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
The goal of this clinical trial is to evaluate the safety and preliminary efficacy of an implantable device that records and stimulates different areas of the brain to allow...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Brain Stem Stroke, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Brain Stem Stroke, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Brain Stem Stroke, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.